Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates
- PMID: 6167667
- DOI: 10.1099/0022-1317-53-2-371
Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates
Abstract
The antigenic specificities of the membrane antigen (MA) complex of three Epstein-Barr (EB) virus-producing cell lines have been compared by complete absorption of an anti-MA antiserum with P3HR-1 cells, followed by testing for residual anti-MA antibody activity against B95-8 and QIMR-WIL cells. Indirect membrane immunofluorescence showed that the absorbed serum, which had lost the capacity to bind P3HR-1 cells, nevertheless gave bright staining on a small proportion of B95-8 cells. SDS-polyacrylamide gel electrophoretic analysis of 125I-labelled MA polypeptides showed that the absorbed serum was able to isolate MA polypeptides from both B95-7 and QIMR-WIL cells, but not from P3HR-2 cells. The results demonstrate that there is substantial sharing of antigenic specificities between the MA determined by three isolates of EB virus, and some antigenic divergence.
Similar articles
-
Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.Clin Exp Immunol. 1983 Aug;53(2):257-71. Clin Exp Immunol. 1983. PMID: 6309441 Free PMC article. Review. No abstract available.
-
Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.Int J Cancer. 1981 Sep 15;28(3):321-7. doi: 10.1002/ijc.2910280311. Int J Cancer. 1981. PMID: 6172392
-
Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides.Int J Cancer. 1980 Aug;26(2):231-40. doi: 10.1002/ijc.2910260216. Int J Cancer. 1980. PMID: 6162806
-
Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.Int J Cancer. 1982 Apr 15;29(4):373-81. doi: 10.1002/ijc.2910290403. Int J Cancer. 1982. PMID: 6282762
-
The Epstein-Barr virus and human lymphoproliferative disorders.Prog Hematol. 1981;12:275-97. Prog Hematol. 1981. PMID: 6280236 Review. No abstract available.
Cited by
-
Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340.EMBO J. 1985 Dec 1;4(12):3229-34. doi: 10.1002/j.1460-2075.1985.tb04070.x. EMBO J. 1985. PMID: 3004944 Free PMC article.
-
Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.Clin Exp Immunol. 1983 Aug;53(2):257-71. Clin Exp Immunol. 1983. PMID: 6309441 Free PMC article. Review. No abstract available.
-
Neutralization of lymphocyte immortalization by different strains of Epstein-Barr virus with a murine monoclonal antibody.Infect Immun. 1982 Sep;37(3):1028-31. doi: 10.1128/iai.37.3.1028-1031.1982. Infect Immun. 1982. PMID: 6182100 Free PMC article.
-
Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes.Proc Natl Acad Sci U S A. 1982 Dec;79(23):7504-8. doi: 10.1073/pnas.79.23.7504. Proc Natl Acad Sci U S A. 1982. PMID: 6296836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources